Philipp Harter
European Network of Gynaecological Oncological Trial Groups (ENGOT)
1
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Giorgio Senaldi, MD, PhD
Daiichi Sankyo
Shared therapeutic areas:
Prof Paul DiSilvestro, MD
Women & Infants Hospital, Providence, Rhode Island, USA
Shared therapeutic areas:
Worked with same sponsors:
Sahar Salehi, MD, PhD
Karolinska Institute and Karolinska University Hospital
Shared therapeutic areas:
Jane Robertson, BSc, MBCHB, MD
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
hisham abo taleb, lecturer
Assiut University
Shared therapeutic areas:
Prof Jan HM Schellens
The Netherlands Cancer Institute, Amsterdam, The Netherlands
Shared therapeutic areas:
Worked with same sponsors:
Dr Johann de Bono, MD
Cancer Research UK, The Institute of Cancer Research, London, UK
Shared therapeutic areas:
Worked with same sponsors:
Prof Kathleen Moore, MD
University of Oklahoma Health Sciences Center, Oklahoma City, USA
Shared therapeutic areas:
Worked with same sponsors:
Jun Zhang, PhD
Fudan University
Shared therapeutic areas:
Rebecca Kristeleit, MD
Guy's Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients
All 1 trials loaded